文献速递心境障碍精神分裂症与精神病性障碍会诊联络精神医学

重性精神疾病与慢性疲劳的肠道菌群失调:一种新的跨诊断构念?系统综述与meta分析

Gut dysbiosis in severe mental illness and chronic fatigue: a novel trans-diagnostic construct? A systematic review and meta-analysis.
PubMed 文献 · Mol Psychiatry · 2021-02-08

作者提出肠道菌群失调可能跨传统诊断边界 underlying 病态行为症状。

要点

  • 重性精神疾病和慢性疲劳患者多种肠道菌群失调替代标志物较健康对照升高。
  • 升高的菌群失调标志物与病态行为严重度呈正相关。
  • 肠道菌群失调可能是跨诊断的病态行为相关机制。

核心结论

  • 重性精神疾病和慢性疲劳患者存在肠道菌群失调替代标志物升高,且与病态行为严重度正相关。
  • 肠道菌群失调可能作为跨传统诊断边界的病态行为 underlying 机制。

研究设计与样本

  • 遵循PRISMA指南的系统综述与meta分析,检索自建库至2020年4月。
  • 采用随机混合模型分析,异质性以I2指数评估。

主要发现

  • 连蛋白在双相障碍和抑郁研究中升高(4项研究,SMD=0.97,95%CI 0.10-1.85,P=0.03,I2=86.61%)。
  • 脂多糖在慢性疲劳和抑郁研究中升高(2项研究,SMD=0.77,95%CI 0.42-1.12,P<0.01,I2=0%)。
  • 抗内毒素抗体在双相障碍、抑郁、精神分裂症和慢性疲劳研究中升高(7项研究,SMD=0.99,95%CI 0.27-1.70,P<0.01,I2=97.14%)。
  • sCD14在双相障碍、抑郁、精神分裂症和慢性疲劳研究中升高(6项研究,SMD=0.54,95%CI 0.16-0.81,P<0.01,I2=90.68%)。
  • LBP在慢性疲劳和抑郁研究中升高(2项研究,SMD=0.87,95%CI 0.25-1.48,P<0.01,I2=56.80%);α1-抗胰蛋白酶在双相障碍、抑郁和精神分裂症研究中升高(6项研究,SMD=1.23,95%CI 0.57-1.88,P<0.01,I2=89.25%)。

临床怎么用

  • 提示临床可关注重性精神疾病和慢性疲劳患者的肠道菌群失调相关标志物。
  • 未来研究应验证跨诊断与分类诊断方法在肠道菌群失调标志物上的表现差异,以推动治疗突破。

局限性

  • 合并分析异质性普遍较高(部分I2>90%),部分标志物纳入研究数量少。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Reduced gut-microbial diversity ("gut dysbiosis") has been associated with an anhedonic/amotivational syndrome ("sickness behavior") that manifests across severe mental disorders and represent the key clinical feature of chronic fatigue. In this systematic review and meta-analysis, we investigated differences in proxy biomarkers of gut dysbiosis in patients with severe mental illness and chronic fatigue vs. controls and the association of these biomarkers with sickness behavior across diagnostic categories. Following PRISMA guidelines, we searched from inception to April 2020 for all the studies investigating proxy biomarkers of gut dysbiosis in patients with severe mental illness and chronic fatigue. Data were independently extracted by multiple observers, and a random-mixed model was used for the analysis. Heterogeneity was assessed with the I2 index. Thirty-three studies were included in the systematic review; nineteen in the meta-analysis (N = 2758 patients and N = 1847 healthy controls). When compared to controls, patients showed increased levels of zonulin (four studies reporting data on bipolar disorder and depression, SMD = 0.97; 95% Cl = 0.10-1.85; P = 0.03, I2 = 86.61%), lipopolysaccharide (two studies reporting data on chronic fatigue and depression, SMD = 0.77; 95% Cl = 0.42-1.12; P < 0.01; I2 = 0%), antibodies against endotoxin (seven studies reporting data on bipolar disorder, depression, schizophrenia, and chronic fatigue, SMD = 0.99; 95% CI = 0.27-1.70; P < 0.01, I2 = 97.14%), sCD14 (six studies reporting data on bipolar disorder, depression, schizophrenia, and chronic fatigue, SMD = 0.54; 95% Cl 0.16-0.81; P < 0.01, I2 = 90.68%), LBP (LBP, two studies reporting data on chronic fatigue and depression, SMD = 0.87; 95% Cl = 0.25-1.48; P < 0.01; I2 = 56.80%), alpha-1-antitripsin (six studies reporting data on bipolar disorder, depression, and schizophrenia, SMD = 1.23; 95% Cl = 0.57-1.88; P < 0.01, I2: 89.25%). Elevated levels of gut dysbiosis markers positively correlated with severity of sickness behavior in patients with severe mental illness and chronic fatigue. Our findings suggest that gut dysbiosis may underlie symptoms of sickness behavior across traditional diagnostic boundaries. Future investigations should validate these findings comparing the performances of the trans-diagnostic vs. categorical approach. This will facilitate treatment breakthrough in an area of unmet clinical need.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Safadi JM, Quinton AMG, Lennox BR, et al. Gut dysbiosis in severe mental illness and chronic fatigue: a novel trans-diagnostic construct? A systematic review and meta-analysis. Mol Psychiatry. 2021. PMID: 33558650. doi:10.1038/s41380-021-01032-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。